Large-scale testing (Phase 3)Study completedNCT02606461What this trial is testingSelinexor in Advanced LiposarcomaWho this might be right forDedifferentiated Liposarcoma Karyopharm Therapeutics Inc 342
Testing effectiveness (Phase 2)Ended earlyNCT03074318What this trial is testingAvelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryWho this might be right forMetastatic LeiomyosarcomaMetastatic LiposarcomaUnresectable Leiomyosarcoma+1 more Fred Hutchinson Cancer Center 35
Early research (Phase 1)Ended earlyNCT05943990What this trial is testingStudy of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell LiposarcomaWho this might be right forNeoplasms Adaptimmune 5
Testing effectiveness (Phase 2)Ended earlyNCT04996004What this trial is testingLearn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With LeiomyosarcomaWho this might be right forLeiomyosarcoma Pfizer 76
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686367What this trial is testingTesting the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare CancersWho this might be right forMetastatic Myxoid LiposarcomaMetastatic Synovial SarcomaUnresectable Myxoid Liposarcoma+1 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871What this trial is testingTesting the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated LiposarcomaWho this might be right forAdvanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more Alliance for Clinical Trials in Oncology 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT05836571What this trial is testingTesting Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue SarcomaWho this might be right forLocally Advanced Extraskeletal Myxoid ChondrosarcomaLocally Advanced LeiomyosarcomaLocally Advanced Liposarcoma+7 more National Cancer Institute LAO 66
Early research (Phase 1)Looking for participantsNCT05711615What this trial is testingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaWho this might be right forMetastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT03967223What this trial is testingMaster Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid TumorsWho this might be right forNeoplasms USWM CT, LLC 103
Testing effectiveness (Phase 2)Study completedNCT02357810What this trial is testingPazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone SarcomasWho this might be right forAdult LiposarcomaMetastatic LiposarcomaMetastatic Osteosarcoma+4 more Northwestern University 178
Testing effectiveness (Phase 2)UnknownNCT04356872What this trial is testingThe Combination of Sintilimab and AI (Doxorubicin, ADM/Ifosfamide, IFO) for the First Line Treatment of Select Type of Metastatic/Unresectable Soft Tissue SarcomaWho this might be right forSarcoma, Soft Tissue Fudan University 45
Testing effectiveness (Phase 2)Study completedNCT03063632What this trial is testingTesting the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial SarcomaWho this might be right forMetastatic Myxoid LiposarcomaMetastatic Round Cell LiposarcomaMetastatic Synovial Sarcoma+13 more National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT02500797What this trial is testingNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by SurgeryWho this might be right forLocally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more National Cancer Institute (NCI) 164
Early research (Phase 1)Active Not RecruitingNCT06414434What this trial is testingBTX-A51 in Patients With Liposarcoma or CIC-rearranged SarcomaWho this might be right forLiposarcomaRecurrent LiposarcomaMetastatic Liposarcoma+4 more Michael Wagner, MD 24
Early research (Phase 1)Ended earlyNCT06048705What this trial is testingStudy of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung CancerWho this might be right forNeoplasms Adaptimmune 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05886634What this trial is testingEtrumadenant and Zimberelimab in People With Dedifferentiated LiposarcomaWho this might be right forDedifferentiated LiposarcomaSoft Tissue SarcomaSarcoma,Soft Tissue+4 more Memorial Sloan Kettering Cancer Center 16
Large-scale testing (Phase 3)Ended earlyNCT01132547What this trial is testingCyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerWho this might be right forCancer University of South Florida 22
Testing effectiveness (Phase 2)Ended earlyNCT01876043What this trial is testingEfficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter TrialWho this might be right forAdult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Institut Bergonié 24
Early research (Phase 1)Study completedNCT00720174What this trial is testingCixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue SarcomaWho this might be right forAdult AngiosarcomaAdult Desmoplastic Small Round Cell TumorAdult Epithelioid Sarcoma+32 more National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Looking for participantsNCT06422806What this trial is testingMeasuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasWho this might be right forMetastatic Dedifferentiated LiposarcomaMetastatic Undifferentiated Pleomorphic SarcomaStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8+3 more National Cancer Institute (NCI) 365